OPX Biotechnologies' Grant

OPX Biotechnologies raised a round of funding on April 19, 2010. Investors include Advanced Research Technologies.

The OPX EDGE (Efficiency Directed Genome Engineering) technology platform enables rapid, rational, and robust optimization of microbes and bioprocesses to manufacture bioproducts with equivalent perfo…

Articles about OPX Biotechnologies' Grant: